Avian Aspergillus Fumigatus Strains Resistant to Both Itraconazole and Voriconazole

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2009 Mar 5

PMID 19258265

Citations 16

Authors

L A Beernaert

F Pasmans

L Van Waeyenberghe

G M Dorrestein

F Verstappen

F Vercammen

F Haesebrouck

A Martel

Affiliations

Soon will be listed here.

Abstract

The in vitro susceptibilities of 59 avian Aspergillus fumigatus strains to amphotericin B, itraconazole, and voriconazole were determined using the standard microdilution broth method (CLSI M38-A2). Four isolates showed acquired resistance to itraconazole and voriconazole, harboring implications for the treatment of aspergillosis in both birds and humans.

Citing Articles

Pan-azole resistance in clinical isolates carrying TR34/L98H from birds and mammals in Belgium.

Debergh H, Haesendonck R, Botteldoorn N, Martel A, Pasmans F, Saegerman C One Health. 2024; 19:100907.

PMID: 39430230 PMC: 11490837. DOI: 10.1016/j.onehlt.2024.100907.

Azole Resistance in Veterinary Clinical Aspergillus fumigatus Isolates in the Netherlands.

van Dijk M, Buil J, Tehupeiory-Kooreman M, Broekhuizen M, Broens E, Wagenaar J Mycopathologia. 2024; 189(4):50.

PMID: 38864903 PMC: 11169034. DOI: 10.1007/s11046-024-00850-5.

Aspergillosis in a colony of Humboldt penguins (Spheniscus humboldti) in a french zoological park: evaluation of environmental exposure.

Bralet T, Risco-Castillo V, Valsecchi I, Laidebeure S, Sailler A, Lecu A Vet Res Commun. 2023; 48(1):437-448.

PMID: 37819485 DOI: 10.1007/s11259-023-10220-z.

Emerging Fungal Infections: from the Fields to the Clinic, Resistant and Dermatophyte Species: a One Health Perspective on an Urgent Public Health Problem.

Langfeldt A, Gold J, Chiller T Curr Clin Microbiol Rep. 2022; 9(4):46-51.

PMID: 36188157 PMC: 9512973. DOI: 10.1007/s40588-022-00181-3.

Gaz Alafi: A Traditional Dessert in the Middle East With Anticancer, Immunomodulatory, and Antimicrobial Activities.

Al Safi M, Rashid H, Afifi F, Talib W Front Nutr. 2022; 9:900506.

PMID: 35845806 PMC: 9283951. DOI: 10.3389/fnut.2022.900506.

References

Pfaller M, Messer S, Boyken L, Rice C, Tendolkar S, Hollis R . In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species. J Clin Microbiol. 2008; 46(8):2568-72. PMC: 2519461. DOI: 10.1128/JCM.00535-08. View

Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela J . Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother. 2004; 48(7):2747-50. PMC: 434164. DOI: 10.1128/AAC.48.7.2747-2750.2004. View

Messer S, Jones R, Fritsche T . International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol. 2006; 44(5):1782-7. PMC: 1479200. DOI: 10.1128/JCM.44.5.1782-1787.2006. View

Manavathu E, Vazquez J, Chandrasekar P . Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent. Int J Antimicrob Agents. 1999; 12(3):213-9. DOI: 10.1016/s0924-8579(98)00102-2. View

Hof H . Critical annotations to the use of azole antifungals for plant protection. Antimicrob Agents Chemother. 2001; 45(11):2987-90. PMC: 90772. DOI: 10.1128/AAC.45.11.2987-2990.2001. View

Beernaert L, Baert K, Marin P, Chiers K, De Backer P, Pasmans F . Designing voriconazole treatment for racing pigeons: balancing between hepatic enzyme auto induction and toxicity. Med Mycol. 2008; 47(3):276-85. DOI: 10.1080/13693780802262115. View

Manavathu E, Abraham O, Chandrasekar P . Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus. Clin Microbiol Infect. 2001; 7(3):130-7. DOI: 10.1046/j.1469-0691.2001.00220.x. View

Manavathu E, Cutright J, Chandrasekar P . In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B. Antimicrob Agents Chemother. 2004; 49(1):428-30. PMC: 538856. DOI: 10.1128/AAC.49.1.428-430.2005. View

Dannaoui E, Persat F, Monier M, Borel E, Piens M, Picot S . In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole. J Antimicrob Chemother. 1999; 44(4):553-5. DOI: 10.1093/jac/44.4.553. View

10.

Dannaoui E, Borel E, Monier M, Piens M, Picot S, Persat F . Acquired itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother. 2001; 47(3):333-40. DOI: 10.1093/jac/47.3.333. View

11.

Beernaert L, Pasmans F, Haesebrouck F, Martel A . Modelling Aspergillus fumigatus infections in racing pigeons (Columba livia domestica). Avian Pathol. 2008; 37(5):545-9. DOI: 10.1080/03079450802382280. View

12.

Somma A, Bailey T, Silvanose C, Garcia-Martinez C . The use of voriconazole for the treatment of aspergillosis in falcons (Falco species). J Avian Med Surg. 2008; 21(4):307-16. DOI: 10.1647/1082-6742(2007)21[307:TUOVFT]2.0.CO;2. View

13.

Verweij P, Te Dorsthorst D, Rijs A, Meis J . Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998. J Clin Microbiol. 2002; 40(7):2648-50. PMC: 120540. DOI: 10.1128/JCM.40.7.2648-2650.2002. View

14.

da Silva Ferreira M, Capellaro J, Marques E, Malavazi I, Perlin D, Park S . In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob Agents Chemother. 2004; 48(11):4405-13. PMC: 525395. DOI: 10.1128/AAC.48.11.4405-4413.2004. View

15.

Xiao L, Madison V, Chau A, Loebenberg D, Palermo R, McNicholas P . Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob Agents Chemother. 2004; 48(2):568-74. PMC: 321559. DOI: 10.1128/AAC.48.2.568-574.2004. View

16.

Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela J . Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification. Antimicrob Agents Chemother. 2008; 52(4):1244-51. PMC: 2292508. DOI: 10.1128/AAC.00942-07. View

17.

Gothard P, Rogers T . Voriconazole for serious fungal infections. Int J Clin Pract. 2004; 58(1):74-80. DOI: 10.1111/j.1368-5031.2004.0099.x. View

18.

Lass-Florl C, Kofler G, Kropshofer G, Hermans J, Kreczy A, Dierich M . In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother. 1998; 42(4):497-502. DOI: 10.1093/jac/42.4.497. View

19.

Rodriguez-Tudela J, Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Monzon A, Cuenca-Estrella M . Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob Agents Chemother. 2008; 52(7):2468-72. PMC: 2443929. DOI: 10.1128/AAC.00156-08. View

20.

Alcazar-Fuoli L, Mellado E, Garcia-Effron G, Lopez J, Grimalt J, Cuenca-Estrella J . Ergosterol biosynthesis pathway in Aspergillus fumigatus. Steroids. 2008; 73(3):339-47. DOI: 10.1016/j.steroids.2007.11.005. View